ConductScience.org, home

Paper17538158

Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag?

Welch SA and 1 other. J Clin Oncol, 2007. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag? Papers, record 17538158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17538158

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination chemotherapy in advanced pancreatic cancer: time to raise the white flag?
PubMed
Journal
J Clin Oncol
PubMed
Year
2007
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.46
iCite
Revised in PubMed
2022-12-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Welch SAStephen A
2Moore MJMalcolm J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Pancreatic NeoplasmsMajor topic
Capecitabine
Deoxycytidine
ErbB Receptors
Fluorouracil
Humans
Randomized Controlled Trials as Topic
Gemcitabine

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on17538165
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group.
https://conductscience.org/library/papers/17538165

Source PubMed

Download CSV of comments and corrections

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
36618103Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic.Glob Chall2023https://conductscience.org/library/papers/36618103PubMed
29998365Phase Ib trial combining capecitabine, erlotinib and bevacizumab in pancreatic adenocarcinoma - REBECA trial.Invest New Drugs2019https://conductscience.org/library/papers/29998365PubMed
28353074Gemcitabine in Combination with a Second Cytotoxic Agent in the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer: a Systematic Review and Meta-Analysis.Target Oncol2017https://conductscience.org/library/papers/28353074PubMed
26317650An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.Oncotarget2015https://conductscience.org/library/papers/26317650PubMed
23846417Considerations for the prediction of survival time in pancreatic cancer based on registry data.J Pharmacokinet Pharmacodyn2013https://conductscience.org/library/papers/23846417PubMed
22233582Myxoma virus sensitizes cancer cells to gemcitabine and is an effective oncolytic virotherapeutic in models of disseminated pancreatic cancer.Mol Ther2012https://conductscience.org/library/papers/22233582PubMed
21740354Bugs and drugs: oncolytic virotherapy in combination with chemotherapy.Curr Pharm Biotechnol2012https://conductscience.org/library/papers/21740354PubMed
20726858Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer.Cancer Sci2010https://conductscience.org/library/papers/20726858PubMed
20101258Advanced pancreatic carcinoma: current treatment and future challenges.Nat Rev Clin Oncol2010https://conductscience.org/library/papers/20101258PubMed
19405981Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.BMC Cancer2009https://conductscience.org/library/papers/19405981PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17538158

GET https://conductscience.org/api/papers/v1/17538158/authors